Placental PHLDA2 expression is increased in cases of fetal growth restriction following reduced fetal movements

BMC Medical Genetics

Volumn 17, Issue 1, 2016, Pages

  Janssen, Anna Bugge ^a   Tunster, Simon J ^a   Heazell, Alexander E P ^b   John, Rosalind M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Fetal growth restriction; PHLDA2; Placenta; Reduced fetal movements; Stillbirth

Indexed keywords

PROLACTIN; NUCLEAR PROTEIN; PLACENTA LACTOGEN; TSSC3 PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BIRTH WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; FETUS MOVEMENT; GENE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MALE; NEWBORN; PERINATAL PERIOD; PHLDA2 GENE; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; PROLACTIN SYNTHESIS; TROPHOBLAST; BLOOD; FETUS DEVELOPMENT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PLACENTA; PREGNANCY; PREGNANCY OUTCOME; STATISTICAL MODEL; STILLBIRTH;

COHORT STUDIES; FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; FETAL MOVEMENT; GENE EXPRESSION REGULATION; HUMANS; INFANT, NEWBORN; LINEAR MODELS; MALE; NUCLEAR PROTEINS; PLACENTA; PLACENTAL LACTOGEN; PREGNANCY; PREGNANCY OUTCOME; STILLBIRTH;

EID: 84962163425     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/s12881-016-0279-1     Document Type: Article

References (29)

1. O'Sullivan O, Stephen G, Martindale E, Heazell AE. Predicting poor perinatal outcome in women who present with decreased fetal movements. J Obstet Gynaecol. 2009;29(8):705-10. doi: 10.3109/01443610903229598.
2. Dutton PJ, Warrander LK, Roberts SA, Bernatavicius G, Byrd LM, Gaze D, Kroll J, Jones RL, Sibley CP, Froen JF, Heazell AE. Predictors of poor perinatal outcome following maternal perception of reduced fetal movements-a prospective cohort study. PLoS One. 2012;7(7):e39784. doi: 10.1371/journal.pone.0039784.
3. Holm Tveit JV, Saastad E, Stray-Pedersen B, Bordahl PE, Froen JF. Maternal characteristics and pregnancy outcomes in women presenting with decreased fetal movements in late pregnancy. Acta Obstet Gynecol Scand. 2009;88(12):1345-51. doi: 10.3109/00016340903348375.
4. Winje BA, Saastad E, Gunnes N, Tveit JV, Stray-Pedersen B, Flenady V, Froen JF. Analysis of 'count-to-ten' fetal movement charts: a prospective cohort study. Bjog. 2011;118(10):1229-38. doi: 10.1111/j.1471-0528.2011.02993.x.
5. Sinha D, Sharma A, Nallaswamy V, Jayagopal N, Bhatti N. Obstetric outcome in women complaining of reduced fetal movements. J Obstet Gynaecol. 2007;27(1):41-3. doi: 10.1080/01443610601016909.
6. Heazell AE, Sumathi GM, Bhatti NR. What investigation is appropriate following maternal perception of reduced fetal movements? J Obstet Gynaecol. 2005;25(7):648-50. doi: 10.1080/01443610500278303.
7. Saastad E, Ahlborg T, Frøen JF. Low maternal awareness of fetal movement is associated with small for gestational age infants. J Midwifery Womens Health. 2008;53(4):345-52. doi: 10.1016/j.jmwh.2008.03.001.
8. Warrander LK, Heazell AE. Identifying placental dysfunction in women with reduced fetal movements can be used to predict patients at increased risk of pregnancy complications. Med Hypotheses. 2011;76(1):17-20. doi: 10.1016/j.mehy.2010.08.020.
9. Warrander LK, Batra G, Bernatavicius G, Greenwood SL, Dutton P, Jones RL, Sibley CP, Heazell AE. Maternal perception of reduced fetal movements is associated with altered placental structure and function. PLoS One. 2012;7(4), e34851. doi: 10.1371/journal.pone.0034851.
10. Winje BA, Roald B, Kristensen NP, Froen JF. Placental pathology in pregnancies with maternally perceived decreased fetal movement-a population-based nested case-cohort study. PLoS One. 2012;7(6):e39259. doi: 10.1371/journal.pone.0039259.
11. Pagani G, D'Antonio F, Khalil A, Papageorghiou A, Bhide A, Thilaganathan B. Association between reduced fetal movements at term and first trimester markers of impaired placental development. Placenta. 2014;35(8):606-10. doi: 10.1016/j.placenta.2014.04.020.
12. Higgins LE, Rey de Castro N, Addo N, Wareing M, Greenwood SL, Jones RL, Sibley CP, Johnstone ED, Heazell AE. Placental features of late-onset adverse pregnancy outcome. PLoS One. 2015;10(6):e0129117. doi: 10.1371/journal.pone.0129117.
13. Gude NM, Roberts CT, Kalionis B, King RG. Growth and function of the normal human placenta. Thromb Res. 2004;114(5-6):397-407. doi: 10.1016/j.thromres.2004.06.038.
14. Surani MA. Imprinting and the initiation of gene silencing in the germ line. Cell. 1998;93(3):309-12.
15. Tunster SJ, Jensen AB, John RM. Imprinted genes in mouse placental development and the regulation of fetal energy stores. Reproduction. 2013;145(5):R117-137. doi: 10.1530/rep-12-0511.
16. Jensen AB, Tunster SJ, John RM. The significance of elevated placental PHLDA2 in human growth restricted pregnancies. Placenta. 2014;35(8):528-32. doi: 10.1016/j.placenta.2014.04.018.
17. Cleaton MA, Edwards CA, Ferguson-Smith AC. Phenotypic outcomes of imprinted gene models in mice: elucidation of pre- and postnatal functions of imprinted genes. Annu Rev Genomics Hum Genet. 2014;15:93-126. doi: 10.1146/annurev-genom-091212-153441.
18. John RM. Epigenetic regulation of placental endocrine lineages and complications of pregnancy. Biochem Soc Trans. 2013;41(3):701-9. doi: 10.1042/bst20130002.
19. Tunster SJ, Tycko B, John RM. The imprinted Phlda2 gene regulates extraembryonic energy stores. Mol Cell Biol. 2010;30(1):295-306.
20. Tunster SJ, Van De Pette M, John RM. Isolating the role of elevated Phlda2 in asymmetric late fetal growth restriction in mice. Dis Model Mech. 2014;7(10):1185-91. doi: 10.1242/dmm.017079.
21. Tunster SJ, Creeth HD, John RM. The imprinted Phlda2 gene modulates a major endocrine compartment of the placenta to regulate placental demands for maternal resources. Dev Biol. 2016;409(1):251-60. doi: 10.1016/j.ydbio.2015.10.015.
22. Janssen AB, Tunster SJ, Savory N, Holmes A, Beasley J, Parveen SA, Penketh RJ, John RM. Placental expression of imprinted genes varies with sampling site and mode of delivery. Placenta. 2015;36(8):790-5. doi: 10.1016/j.placenta.2015.06.011.
23. Apostolidou S, Abu-Amero S, O'Donoghue K, Frost J, Olafsdottir O, Chavele K, Whittaker J, Loughna P, Stanier P, Moore G. Elevated placental expression of the imprinted PHLDA2 gene is associated with low birth weight. J Mol Med. 2007;85(4):379-87. doi: 10.1007/s00109-006-0131-8.
24. O'Donnell KJ, Bugge Jensen A, Freeman L, Khalife N, O'Connor TG, Glover V. Maternal prenatal anxiety and downregulation of placental 11beta-HSD2. Psychoneuroendocrinology. 2012;37(6):818-26. doi: 10.1016/j.psyneuen.2011.09.014.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-8. doi: 10.1006/meth.2001.1262.
26. Doria S, Sousa M, Fernandes S, Ramalho C, Brandao O, Matias A, Barros A, Carvalho F. Gene expression pattern of IGF2, PHLDA2, PEG10 and CDKN1C imprinted genes in spontaneous miscarriages or fetal deaths. Epigenetics. 2010;5(5):444-50.
27. Cordeiro A, Neto AP, Carvalho F, Ramalho C, Doria S. Relevance of genomic imprinting in intrauterine human growth expression of CDKN1C, H19, IGF2, KCNQ1 and PHLDA2 imprinted genes. J Assist Reprod Genet. 2014;31(10):1361-8. doi: 10.1007/s10815-014-0278-0.
28. Newbern D, Freemark M. Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes. 2011;18(6):409-16. doi: 10.1097/MED.0b013e32834c800d.
29. Draper E, Kurinczuk J, Kenyon S, on behalf of MBRRACE-UK. MBRRACE-UK Perinatal Confidential Enquiry: Term, singleton, normally formed, antepartum stillbirth. Leicester: The Infant Mortality and Morbidity Studies, Department of Health Sciences, University of Leicester; 2015.